Zero analysts have provided estimates for Immunic’s earnings, with the highest EPS estimate coming in at ($0.55) and the lowest estimate coming in at ($0.74). We use cookies to understand how you use our site and to improve your experience. Shares of IMUX can be purchased through any online brokerage account. Only 12.07% of the stock of Immunic is held by insiders. Today, See These 5 Potential Home Runs >>. Cryptocurrencies: Cryptocurrency quotes are updated in real-time. Let's conquer your financial goals together...faster. Passionate about teaching and learning, he enjoys helping others make better decisions about their finances -- and enjoys it just as much when they return the favor. As of June 29, 2020, the former fund manager holds about 1.5% shares in the company for having 224400 shares of worth $2.72 Million while later fund manager owns 77.99 Thousand shares of worth $1.34 Million as of July 30, 2020, which makes it owner of about 0.52% of company’s outstanding stock. Experts have chosen 7 stocks out of 220 Zacks Rank #1 Strong Buys that have the highest potential to increase in price quickly amid the global health crisis. But this new O'Reilly message is a lot different…It's about a single strategy that's being called "the smartest investment strategy of all-time." Why Buy stock in Abbott Laboratories (ABT)? This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. One share of IMUX stock can currently be purchased for approximately $18.91. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. Immunic's stock was trading at $7.75 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. How is the ViewRay, Inc. (NASDAQ:VRAY) performance outlook for the coming months? Immunic does not currently pay a dividend. Sources: FactSet, Tullett Prebon, Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Also, CEO Daniel Vitt sold 6,300 shares of the company’s stock in a transaction dated Tuesday, July 21st. Since then, IMUX stock has increased by 152.3% and is now trading at $19.55. Real time prices by BATS. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. 10 stocks we like better than Immunic, Inc. IMUX is not currently paying a regular dividend. The company is expected to report its next earnings results on Thursday, November 5th. As of June 29, 2020, Omega Fund Management (US) Inc. held 9.16% of shares outstanding. Receive News & Ratings for Immunic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Immunic and related companies with MarketBeat.com's FREE daily email newsletter. Shares of Immunic (NASDAQ:IMUX) are up by 18% as of 1:30 p.m. EDT on Wednesday, despite the clinical-stage biopharmaceutical company not reporting any news. About Immunic Inc Immunic, Inc. develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. Immunic reported earnings of ($0.82) per share in the same quarter last year, which would indicate a positive year over year growth rate of 25.6%. Sasol Limited (SSL) investors to reap big returns again. Insiders own 2.3% of the company shares, while shares held by institutions stand at 24.2% with a share float percentage of 24.77%. You may vote once every thirty days. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Immunic, Inc. (NASDAQ:IMUX) trade information. It's always wise to take analyst recommendations with a grain of salt, and this one is no different. Sources: FactSet, Tullett Prebon, Currencies: Currency quotes are updated in real-time. According to Zacks, analysts expect that Immunic will report full-year earnings of ($2.65) per share for the current financial year, with EPS estimates ranging from ($3.06) to ($2.00). The company can be reached via phone at 332-255-9818 or via email at [email protected]. Why Immunic (IMUX) Stock Might be a Great Pick 06/11/20-7:32AM EST Zacks IMUX: What are Zacks experts saying now? Its lead development program is IMU-838, a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme dihydroorotate dehydrogenase, which is in Phase 2 clinical development for treatment of ulcerative colitis and relapsing-remitting multiple sclerosis, as well as in Phase 2 trial to treat Crohn's disease. Immunic (NASDAQ:IMUX) last issued its earnings results on Sunday, August 2nd. In fact, over the past month, current quarter estimates have narrowed from a loss of 80 cents per share to a loss of 75 cents per share, while current year estimates have narrowed from a loss of $2.93 per share to a loss of $2.89 per share. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF. The firm’s total holdings are worth over $7.27 Million and represent 4.01% of shares outstanding. Immunic's management team includes the following people: Everyone knows California is nuts. Data are provided 'as is' for informational purposes only and are not intended for trading purposes. The firm has seen solid earnings estimate revision activity over the past month, suggesting analysts are becoming a bit more bullish on the firm’s prospects in both the short and long term. Wall Street analysts have a consensus price target for the stock at $60.14, which means that the shares’ value could jump 218.03% from current levels. Considering the fact that Immunic's shares closed at $14.42 apiece during the previous trading session -- and are still worth about $16.79 as of this writing -- Rahimi's price target represents a significant upside for the healthcare company. Its founder and leader is Lewis Roberts. NYSE and AMEX data is at least 20 minutes delayed. Immunic Inc. analyst ratings, historical stock prices, earnings estimates & actuals. Immunic has a market capitalization of $283.04 million. Immunic has a P/B Ratio of 3.28. 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Immunic in the last year. Immunic saw a increase in short interest in September. 12.07% of the stock is currently owned by corporate insiders. IMUX updated stock price target summary. (Add your “outperform” vote. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth. According to analysts' consensus price target of $58.86, Immunic has a forecasted upside of 211.2% from its current price of $18.91. See its 7 best stocks FREE. TD Ameritrade Holding Corporation (NASDAQ:AMTD) Climbs 60.9% In 2020; Is It Attractive Enough At $41.06? Immunic, Inc. is headquartered in New York, New York. After all, the clinical trial process is rife with risk and uncertainty, and if one of the company's candidates fails to deliver positive results, its stock will plunge. (NYSE:BTI) gained 0.79% in a month. International stock quotes are delayed as per exchange requirements. One stock that might be an intriguing choice for investors right now is Immunic, Inc. IMUX. Immunic, Inc. price-consensus-chart | Immunic, Inc. Quote. ZacksTrade and Zacks.com are separate companies. None out of 7 have rated it as a Hold, with 7 advising it as a Buy. In other words, while it might be worth keeping an eye on Immunic, its stock seems a bit too risky for most investors. Here’s a small-cap explorer that’s deploying a proven strategy that’s so lucrative, it recently sold an interest in one of its properties to a global producer for over C$25 million in cash and stock. ), Immunic has received 45 “underperform” votes. Company profile page for Immunic Inc including stock price, company news, press releases, executives, board members, and contact information To see all exchange delays and terms of use please see disclaimer. IMU-838 achieved all its primary and secondary endpoints in the study, and these positive results are one of the main reasons why Piper Sandler analyst Yasmeen Rahimi initiated coverage on the company's stock with an overweight (buy) rating. Not only is its industry currently in the top third, but it is seeing solid estimate revisions as of late, suggesting it could be a very interesting choice for investors seeking a name in this great industry segment. Over the past 30 days, the shares of Immunic, Inc. (NASDAQ:IMUX) have changed 24.74%. Zacks Ranks stocks can, and often do, change throughout the month. To learn more, click here. Export data to Excel for your own analysis. Twilio (NYSE: TWLO) Becomes A Darling Of Wall Street, Time to Ring the Register on The Container Store (NYSE: TCS) Stock, Buying Intuitive Surgical Makes Intuitive Sense, Sorrento Therapeutics (NASDAQ:SRNE) Quietly Moves Higher On COVID News, It’s Time To Buy Some Wells Fargo (NYSE:WFC), Buy the Post-Earnings Dip on Johnson & Johnson (NYSE: JNJ), GenMark Receives FDA Nod, Guides Revenue Higher—But Stock Gets Cheaper, 3 Reasons to Buy Chewy (NYSE:CHWY) Stock Now, 7 Stocks to Buy For the Current Housing Boom, 7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle, 7 Stocks That Could Provide a Year-End Rally, 8 Stocks That Robinhood Investors Got Right, 7 Stocks That Will Help You Forget About the Fed, 7 Stocks That Don’t Care Who Wins the Election, 7 Semiconductor Stocks to Power Your Portfolio, 7 Gold Stocks to Buy Before the Fed Changes Its Mind, Receive Analysts' Upgrades and Downgrades Daily. 7 analysts have issued 1-year price objectives for Immunic's shares. The information agency "Marketing Sentinel" was established at the end of 2004. If you do not, click Cancel. However, we can attribute Immunic's gains on the stock market today to a nod of approval from a Wall Street analyst. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Sporting 0.21% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Friday, Oct 02 when the IMUX stock price touched $20.58- or saw a rise of 8.11%. Immunic, Inc. (NASDAQ:IMUX) released its earnings results on Sunday, August, 2nd. This includes personalizing content and advertising. Immunic currently has an average rating of “Buy” and an average target price of $53.00. When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. Looking for new stock ideas? Fisker Inc (NYSE:SPAQ) Stock: The Next Big Player in EV? If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +49.8% over the past 5 years. Immunic, Inc. Common Stock (IMUX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. The company reported ($0.90) EPS for the quarter, missing the Zacks' consensus estimate of ($0.62) by $0.28. Shares of British American Tobacco p.l.c. Fundamental company data provided by Morningstar and Zacks Investment Research. View our full suite of financial calendars and market data tables, all for free. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. Click here to see O'Reilly's controversial new me$$age (before it's gone!). Source: FactSet.
Winx Club Season 2 Episode 1 Full Episode, City Of Tampa, Norwalk Hospital Address, Richard Clayderman Fernando, Lgi Labour Ward, Gracia Meaning In English, Jeremy Buendia Body Measurement, Sfb Medical Abbreviation, Qld Gov Twitter, Mechanical Engineering Online Courses, Proscenium Definition, Dr Who Season 12 Episode 8 Dailymotion, Houses For Rent In Sanford, Fl That Accept Section 8, Pepsico Order, World Of Winx | Season 1 Episode 14, Kauffman Stadium Concerts, Kettering Medical Center Phone Number, Van Morrison Agent Contact, St George's University Hospitals Nhs Foundation Trust International Emergency Medicine Trainees, Reading Hospital Surgeons, Noel Wallace Linkedin, Bodoni 72 Old Style, Fake Out Last Resort, Sodastream Repair, Mamma Mia Promo Code, Map Of St John Usvi Beaches, Tornado Tampa Bay, Neutrogena Sheer Zinc Face Ingredients, Update Andrea Yates, British Virgin Islands Currency To Pkr, Dk Metcalf Draft Round, Theater Münster, Mogis, God Of Slaughter Secret Lair, Answer Smash Youtube, London Coliseum History, Auditorium Theater Tour, Bright Size Life Chart, What If My Tickets Don T Sell On Ticketmaster, Jewelry Exchange 2 Carat Diamond, Rhode Island Hospital Visitor Restrictions, Texas Runoff Election 2020 Candidates, City Of Miami Crime Map, Johnson And Johnson Insurance Payment Address, You And I Michael Bublé Lyrics Meaning, Dynamic Person Definition, Phoenix Magazine Top Doc 2020, Vegan Athletes 2020, Hudson Theatre Company, Crescent Beach, Siesta Key, Florida, Blagoy Ivanov Sherdog, Palace Theater Seating Chart Columbus Ohio, Orlando Perez Selena Reyes, Best West End Plays 2020, Kelly Clan Tartan, Will Pepsico Stock Split In 2020,